严重的血管需要呼吸道干预后evolocumab的管理:一个病例报告

Azad Mojahedi¹, Adam Friedman², Iyad Idries¹

¹Department of Internal Medicine, Brookdale University Hospital and Medical Center Brooklyn, New York, United States.

American journal of cardiovascular disease

|November 24, 2025

概括

作为PCSK9抑制剂的Evolocumab可以导致罕见但严重的血管. 这一案例详细介绍了一名患者由于evolocumab引起的呼吸道阻塞而需要输管,强调了其潜在的风险.

科学领域:

心脏病学心脏病学
药理学药理学是指药理学的学科.
免疫学免疫学免疫学

背景情况:

埃沃洛库马布是一种用于高脂血症的PCSK9抑制剂.
虽然通常是安全的,但严重的过敏反应,如血管是罕见的.
之前关于使用evolocumab引起严重血管的报道有限,特别是在美国.

研究的目的:

在evolocumab开始后报告严重的血管与呼吸道损害的病例.
为了突出一种罕见的,可能危及生命的evolocumab治疗不良影响.

主要方法:

一个64岁的女性患者的病例报告.
患者呈现了ST升高心肌梗塞,并接受了evolocumab治疗耐火性高脂血症.
临床表现,诊断程序 (喉腔镜检查) 和管理 (输管,医疗疗) 都被记录下来.

主要成果:

患者在开始使用evolocumab的24小时内出现了迅速发作的舌头和面部胀.
口腔水导致呼吸道阻塞,需要紧急内管内输管.
症状通过皮质类固醇和抗组胺药物得到缓解,允许输出管和排出.

结论:

这种病例代表了严重的,以前没有报告的血管反应,需要在美国患者接受evolocumab治疗时进行呼吸道干预.
临床医生应对PCSK9抑制剂的罕见但严重的过敏反应保持警.
及时识别和管理对于诸如evolocumab诱导的血管等不良事件至关重要.

关键词:

蛋白转化酶亚提利辛-凯类型9 血管内血管内进化了你的生活过敏性过敏性过敏性输入管道是输入管道的方法.

相关概念视频

01:27

Allergic Drug Reactions

1.6K

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...

1.6K

01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

2.4K

01:30

Allergic Reactions: Anaphylaxis

293

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...

293

01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

764

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

764

01:27

Pulmonary Embolism III: Nursing Management

759

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

759

01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...